Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

From AI-powered drug discovery to regenerative therapies and next-generation neurology tools, Mayo Clinic researchers made ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

Explore how Insilico collaborates with Servier to advance AI-driven drug discovery in oncology for unmet medical needs.

Jiangsu Hengrui Pharma has chalked up a first-in-class approval for retlirafusp alfa, a bifunctional drug that targets PD-L1 ...

A new discovery could pave the way for more effective cancer treatment by helping certain drugs work better inside the body. Scientists at Duke University School of Medicine, University of Texas ...

The discovery could pave the way for new treatments, improved risk prediction, and earlier intervention for brain metastases.

Predictive Oncology aims to enhance drug discovery using its biobank and AI, following industry trends exemplified by Regeneron's 23andMe acquisition. Predictive Oncology Inc. is leveraging its ...

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating side effect. The compound was developed by Lawrence Livermore National ...

A previously unknown protein in a family of bacteria found in soil and the human gut microbiome has been discovered – which could help drug delivery in cancer treatment. In a paper published in PNAS, ...

Looks like Ozempic isn’t the only diabetes drug that wound up having a secret side hustle. A team of Swedish researchers has discovered that a drug traditionally meant for Type 2 diabetes shows ...

Scientists studying an existing blood pressure drug called hydralazine accidentally discovered that it could potentially fight cancer. Hydralazine has been used to treat high blood pressure since the ...